New technology assessment and current and upcoming therapies for underactive bladder.
Michael B ChancellorSarah N BartoloneElise M DeVriesAnanias C DioknoMark GibbonsRonald JankowskiLaura E LambRyan PruchnicKarl ThorCharles W ButrickPublished in: Neurourology and urodynamics (2018)
The UAB regulatory working group recognizes the path forward should include engaging the FDA and other regulatory organizations that may harmonize and formalize guidance for regulatory trial designs for therapeutics for UAB.